Prevalence of Contact Allergy to Isothiazolinones in Dermatitis Patients From 2000 to 2025: A Systematic Review and Meta‐Analysis
Contact Dermatitis · 2026
DOI: 10.1111/cod.70124 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Contact Dermatitis, 2026. Verfasst von Daniel Isufi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Herlev and Gentofte-Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Thiazoles, Dermatitis, Allergic Contact, Preservatives, Pharmaceutical, Cosmetics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Danish Environmental Protection Agency under the Ministry of Environment of Denmark.
Abstract (Originalsprache)
Isothiazolinones are employed in the preservation of cosmetic, consumer and industrial products, with the objective of preventing deterioration and spoilage. However, the utilization of isothiazolinones is associated with an elevated risk of developing contact allergy (CA). Herein, we assess the epidemiology of CA to isothiazolinones among dermatitis patients from year 2000 onwards. We systematically searched PubMed, Embase, and Web of Science from 1 January 2000 to 19 April 2025 yielding 115 studies comprising 1 514 781 dermatitis patients. The prevalence of CA to methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) was 4.58%, methylisothiazolinone (MI) was 5.48%, and benzisothiazolinone (BIT) was 2.09%. The clinical relevance ranged from 60.1% for MCI/MI, 55.6% for MI, and 35.3% for BIT. Asia and North and South America exhibited the highest rates of CA to isothiazolinones, whereas Europe showed lower rates. These findings underscore the efficacy of proactive risk management for post‐marketed substances such as MI, underscoring substantial regional variations in usage patterns, which are contingent on the strictness or permissiveness of their incorporation into everyday consumer products. There is an indication of a decline, particularly regarding MI and MCI/MI. However, there has been an increase in the use of substances such as BIT, which necessitates enhanced surveillance measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergy, Herlev and Gentofte-Copenhagen University Hospital, Copenhagen, Denmark.
- National Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Copenhagen, Denmark.
- Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Daniel Isufi, Kian Karimian, Mikkel Bak Jensen, Rebekka Søgaard, Jeanne Duus Johansen, Jakob Ferløv Baselius Schwensen
Förderung
- The Danish Environmental Protection Agency under the Ministry of Environment of Denmark
Zitieren
APA
Isufi, D., Karimian, K., Jensen, M. B., Larsen, C. K., Søgaard, R., Johansen, J. D., & Schwensen, J. F. B. (2026). Prevalence of Contact Allergy to Isothiazolinones in Dermatitis Patients From 2000 to 2025: A Systematic Review and Meta‐Analysis. Contact Dermatitis. https://doi.org/10.1111/cod.70124
Vancouver
Isufi D, Karimian K, Jensen MB, Larsen CK, Søgaard R, Johansen JD, et al. Prevalence of Contact Allergy to Isothiazolinones in Dermatitis Patients From 2000 to 2025: A Systematic Review and Meta‐Analysis. Contact Dermatitis. 2026. doi:10.1111/cod.70124
BibTeX
@article{Isufi2026,
author = {Isufi, Daniel and Karimian, Kian and Jensen, Mikkel Bak and Larsen, Christoffer Kursawe and Søgaard, Rebekka and Johansen, Jeanne Duus and Schwensen, Jakob Ferløv Baselius},
title = {Prevalence of Contact Allergy to Isothiazolinones in Dermatitis Patients From 2000 to 2025: A Systematic Review and Meta‐Analysis},
journal = {Contact Dermatitis},
year = {2026},
doi = {10.1111/cod.70124}
}
EUVIMED